FDA Recalls: Generic Adderall and Levothyroxine
FDA Recalls: Generic Adderall and Levothyroxine Multiple FDA recalls in July 2026 highlight systemic risks in generic medications and dietary supplements, including a mix-up in generic Adderall XR capsules, subpotent levothyroxine tablets, and salmonella-tainted moringa supplements. Independent reporting reveals overlapping vulnerabilities in pharmaceutical supply chains and supplement oversight. In July 2026, the U.S. Food and … Read more